|
|
Blood, 1 August 2006, Vol. 108, No. 3, pp. 915-921.
Prepublished online as a Blood First Edition Paper on March 30, 2006; DOI 10.1182/blood-2006-03-006478.
 Previous Article | Table of Contents | Next Article 
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin
Zia A. Khan,
Juan M. Melero-Martin,
Xiao Wu,
Sailaja Paruchuri,
Elisa Boscolo,
John B. Mulliken, and
Joyce Bischoff
From the Vascular Biology Program and Department of Surgery and Division of Plastic Surgery, Children's Hospital Boston, Harvard Medical School, Boston, MA.
Infantile hemangiomas are composed of endothelial cells (ECs), endothelial progenitor cells (EPCs), as well as perivascular and hematopoietic cells. Our hypothesis is that hemangioma-derived EPCs (HemEPCs) differentiate into the mature ECs that comprise the major compartment of the tumor. To test this, we isolated EPCs (CD133+/Ulex europeus– I+) and mature ECs (CD133–/Ulex europeus–I+) from proliferating hemangiomas and used a previously described property of hemangioma-derived ECs (HemECs), enhanced migratory activity in response to the angiogenesis inhibitor endostatin, to determine if HemEPCs share this abnormal behavior. Umbilical cord blood–derived EPCs (cbEPCs) were analyzed in parallel as a normal control. Our results show that HemEPCs, HemECs, and cbEPCs exhibit increased adhesion, migration, and proliferation in response to endostatin. This angiogenic response to endostatin was consistently expressed by HemEPCs over several weeks in culture, whereas HemECs and cbEPCs shifted toward the mature endothelial response to endostatin. Similar mRNA-expression patterns among HemEPCs, HemECs, and cbEPCs, revealed by microarray analyses, provided further indication of an EPC phenotype. This is the first demonstration that human EPCs, isolated from blood or from a proliferating hemangioma, are stimulated by an angiogenesis inhibitor. These findings suggest that EPCs respond differently from mature ECs when exposed to angiogenic or antiangiogenic signals.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S. Yuan, Y. Fu, X. Wang, H. Shi, Y. Huang, X. Song, L. Li, N. Song, and Y. Luo
Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis
FASEB J,
August 1, 2008;
22(8):
2809 - 2820.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Greene, S. Kim, G. F. Rogers, S. J. Fishman, B. R. Olsen, and J. B. Mulliken
Risk of Vascular Anomalies With Down Syndrome
Pediatrics,
January 1, 2008;
121(1):
e135 - e140.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Shi, Y. Huang, H. Zhou, X. Song, S. Yuan, Y. Fu, and Y. Luo
Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin
Blood,
October 15, 2007;
110(8):
2899 - 2906.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Schmidt, K. Brixius, and W. Bloch
Endothelial Precursor Cell Migration During Vasculogenesis
Circ. Res.,
July 20, 2007;
101(2):
125 - 136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Melero-Martin, Z. A. Khan, A. Picard, X. Wu, S. Paruchuri, and J. Bischoff
In vivo vasculogenic potential of human blood-derived endothelial progenitor cells
Blood,
June 1, 2007;
109(11):
4761 - 4768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Paruchuri, J.-H. Yang, E. Aikawa, J. M. Melero-Martin, Z. A. Khan, S. Loukogeorgakis, F. J. Schoen, and J. Bischoff
Human Pulmonary Valve Progenitor Cells Exhibit Endothelial/Mesenchymal Plasticity in Response to Vascular Endothelial Growth Factor-A and Transforming Growth Factor-{beta}2
Circ. Res.,
October 13, 2006;
99(8):
861 - 869.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
